Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.275 USD | -5.99% |
|
-4.41% | -56.25% |
Chart calendar Salarius Pharmaceuticals, Inc.
Upcoming events on Salarius Pharmaceuticals, Inc.
Past events on Salarius Pharmaceuticals, Inc.
2024-06-13 | European Hematology Association Hybrid Congress |
2024-05-09 11:00 am | Special Meeting |
2024-03-22 04:05 pm | Q4 2023 Earnings Release |
2023-08-10 04:05 pm | Q2 2023 Earnings Release |
2023-07-11 | Tumor Models Conference |
2023-06-14 11:00 am | Annual General Meeting |
2023-06-07 | European Hematology Association Hybrid Congress |
2023-06-04 | BIO International Convention |
2023-05-11 08:00 am | Q1 2023 Earnings Release |
2023-04-19 09:00 am | American Association for Cancer Research Meeting - Abstract No 6253 |
2023-04-16 01:30 pm | American Association for Cancer Research Meeting - Abstract No 524 |
2023-04-05 11:00 am | Diamond Equity Research Research Emerging Growth Invitational Conference |
2023-03-27 08:30 am | Q4 2022 Earnings Release |
2023-01-25 | Molecular Glue Drug Development Summit |
2022-12-14 11:00 am | Business Update Call |
2022-12-12 | American Society of Hematology Meeting - Abstract No 170138 |
2022-12-12 | American Society of Hematology Meeting - Abstract No 167495 |
2022-11-10 08:30 am | Q3 2022 Earnings Release |
2022-10-26 05:30 pm | Targeted Protein Degradation Summit |
2022-10-05 | American Association of Cancer Research Special Conference |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 3,47 3,32 4.37% | 5,23 5,25 -0.25% | 1,84 3,14 -41.3% | 0,00 0,00 - | 0,00 | 0,00 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | 0,00 0,00 - | -7,79 -8,04 3.11% | 0,00 0,00 - | 0,00 0,00 - | 0,00 | -22,1 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -12,8 -13,0 1.78% | 0,00 0,00 - | 0,00 | 0,00 |
Net income Million USD | Released Forecast Spread | 0,00 0,00 - | -7,35 -7,59 3.17% | -12,8 -13,0 1.78% | -31,6 -22,3 -41.82% | -12,5 | -21,9 |
EPS USD | Released Forecast Spread | 0,00 0,00 - | -100 -110 9.09% | -62,0 -60,0 -3.33% | 0,00 -6,80 - | -30,7 | -214 |
Announcement Date | 23/03/20 | 18/03/21 | 10/03/22 | 27/03/23 | 22/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -5,42 -5,97 9.25% | -3,97 -4,71 15.72% | -2,53 -4,02 37% | ||||||||||
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,34 | ||||||||||||
Net income Million USD | Released Forecast Spread | -6,11 -4,32 -41.35% | -4,72 -4,52 -4.5% | -14,4 -4,94 -191.87% | -6,37 -5,79 -10.01% | -5,34 -5,95 10.21% | -3,88 -4,69 17.26% | -2,44 -3,97 38.46% | ||||||
EPS USD | Released Forecast Spread | -26,0 -18,0 -44.44% | -18,0 -20,0 10% | -51,3 -18,0 -184.89% | -22,0 -17,9 -22.77% | -17,8 -19,4 8.04% | -11,4 -10,4 -10.28% | -5,20 -10,7 51.31% | -3,28 -53,6 93.88% | -53,6 | -53,6 | -53,7 | -46,8 | -46,8 |
Announcement Date | 12/05/22 | 05/08/22 | 10/11/22 | 27/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 13/05/24 | - | - | - | - | - |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Salarius Pharmaceuticals, Inc.
2024-06-07 02:57 am | POLARIS GROUP: May 2024 Sales and Revenue Release |
2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SLRX Stock
- Calendar Salarius Pharmaceuticals, Inc.